Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News on Diabetes

Vegas teachers are getting lapband surgery paid for if they don’t put weight back on

Over 50 teachers in the Clark County School District have taken advantage of the program, which reimburses the $5,000 copay for bariatric surgery if they keep the weight off for five years.

The Independent UK

New study finally busts health myth of much-loved tropical fruit

New study finally busts health myth of much-loved tropical fruit

Clinical trials replaced breakfast bread with a mango and monitored glycemic responses

The Independent UK

Patients warned not to turn to fake weight loss jabs after UK Mounjaro price hike

Patients warned not to turn to fake weight loss jabs after UK Mounjaro price hike

Pharmacists fear rise in sale of dangerous counterfeit medicines as drugmaker triples price of prescription

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Millions of people ‘could be denied weight-loss jabs due to flawed NHS guidance’

NHS BMI measures ‘don’t work for around 3 million patients’, a health analyst has warned

The Independent UK

Mounjaro weight-loss drug price to almost triple in UK after Trump complaint

At least 500,000 people in the UK take either Mounjaro or Wegovy, another weight-loss jab, through private prescriptions

The Independent UK

Drug that slows onset of type 1 diabetes licensed for use in UK-first

The cost-effectiveness of the drug for NHS roll-out will now be assessed by the National Institute for Health and Care Excellence.

Evening Standard

Eli Lilly To Raise Mounjaro Price In UK, Expands Obesity Drug Push In India

Eli Lilly and Co. (NYSE:LLY) will sharply increase the list price of its weight-loss and type 2 diabetes drug Mounjaro (tirzepatide) in the United Kingdom, while expanding its market presence in India with a new injector pen.

inkl

Read news from The Economist, FT, and more,
with one subscription

Weighing The Costs: Obesity Drug Users Make Financial Sacrifices As Coverage Tightens

Weighing The Costs: Obesity Drug Users Make Financial Sacrifices As Coverage Tightens

Vacations are on hold, dinners out skipped, and doses stretched — all so patients can keep taking weight-loss drugs like Wegovy and Zepbound as insurers pull back coverage in 2025.

UK Government, Eli Lilly Partner To Target Obesity Health Gaps

UK Government, Eli Lilly Partner To Target Obesity Health Gaps

A new program to improve access to weight management services across the U.K. National Health Service (NHS) could benefit several obese patients.

Study links weight-loss drugs to serious eye conditions and vision loss

Study links weight-loss drugs to serious eye conditions and vision loss

Researchers suggest all diabetes patients on weight-loss drugs should be regularly screened and monitored for potential eye complications

The Independent UK

Insulet Peer Tandem Diabetes Underwhelming Earnings, Dull Outlook Drags Stock

Insulet Peer Tandem Diabetes Underwhelming Earnings, Dull Outlook Drags Stock

Tandem Diabetes Care Inc.’s (NASDAQ:TNDM) stock plunged on Thursday after the company cut its annual guidance.

Hold the fries! How your favorite salty side can increase your risk of type 2 diabetes

Hold the fries! How your favorite salty side can increase your risk of type 2 diabetes

The study found eating three servings of fries a week could increase your risk of developing type 2 diabetes by 20 percent

The Independent UK

Eating chips three times a week raises type 2 diabetes risk by 20%, study finds

Eating chips three times a week raises type 2 diabetes risk by 20%, study finds

Baking, boiling or mashing potatoes raises risk by 5% and replacing with whole grains lowers risk significantly

The Guardian - UK

Sales of Novo Nordisk’s diabetes drugs including Ozempic slow sharply

Sales of Novo Nordisk’s diabetes drugs including Ozempic slow sharply

Danish company to cut costs and consider layoffs after competition from Mounjaro and the copycat market

The Guardian - UK

Get all your
news in one place.

100's of premium titles.
One news app.

Bryan Johnson Spent Millions To Be 18 Again—Says Novo Nordisk's Ozempic Anti-Aging Hype Is Misleading: 'Data Is Not There'

Tech entrepreneur Bryan Johnson, who spends $2 million annually on anti-aging treatments, refutes claims that Novo Nordisk AS‘s (NYSE:NVO) Ozempic demonstrates anti-aging properties. Johnson disputed a post on social platform X suggesting the diabetes drug reverses biological aging by 3.1 years.

The Independent UK

Ozempic could be hurting your gym gains — with potentially dangerous consequences

The popular weight loss drug shrank the liver of mice by nearly half their size, researchers said

The Independent UK

Thousands of patients miss out on weight loss jab due to NHS ‘postcode lottery’

Doctors have warned that patients are being ‘set up for failure’ due to mismanagement of the rollout of Mounjaro

The Independent UK

Experts reveal potential side effect of Ozempic – and whether we should worry

Researchers found Ozempic-induced weight loss decreased muscle mass by about 10 per cent

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Avoiding these foods could help people lose twice as much weight, study finds

Those who were given a diet of pre-packaged breakfast bars and shop-bought sandwiches ate more calories than those who ate meals cooked from scratch

The Independent UK

Humans may have hibernation ‘superpowers’ in untapped genes, scientists say

Hibernating animals avoid muscle and nerve decay and stay healthy despite massive weight fluctuations

The Guardian - UK

Lucy Letby: Beyond Reasonable Doubt? review – one of the most meticulous documentaries in years

The science and statistics around Letby’s case are brilliantly unpacked by this considered programme. By its end, you are filled with questions

The Guardian - AU

Online shoppers warned of ‘dangerous’ weight-loss scam as ‘ghost stores’ impersonate real people to sell Ozempic-like treatments

Dietitian Lyndi Cohen says her likeness is being ‘abused and misrepresented’ as websites posing as Australian businesses claim to offer GLP-1 substances

Trump Administration Plan Signals Shift Toward Weight-Loss Drug Coverage For Medicare Patients

The Trump administration is preparing a pilot program that could allow some Americans on Medicare and Medicaid to access popular and costly weight-loss medications.

The Guardian - US

Trump officials plan coverage for weight loss drugs under Medicare and Medicaid

Pilot program, first pitched under Biden, will cover GLP-1 drugs such as Ozempic to address chronic obesity in US

The Independent UK

Ultra-processed baby foods ‘set children up for lifetime of obesity,’ experts warn

A study has found that one in three baby food products as classed as ultra-processed foods

1 … 12 13 14 15

People

188,832 stories

Elizabeth Robertson

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

The Independent

Guardian Australia

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

372,819 stories

138,750 stories

The United States

the United Kingdom

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play